Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced Ovarian Cancer: A Clinical Study of 100 Patients

Figure 2

OS and PFS in the AOC patients. (a) OS of 100 AOC patients. (b) PFS of 79 AOC patients with complete CRS+HIPEC.

(a)

(b)